The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy.

PubWeight™: 5.10‹?› | Rank: Top 1%

🔗 View Article (PMID 31142513)

Published in Cancer Res on May 29, 2019

Authors

Kostyantyn Krysan1,2, Linh M Tran3, Brandon S Grimes3, Gregory A Fishbein4, Atsuko Seki4, Brian K Gardner3, Tonya C Walser3, Ramin Salehi-Rad3,2, Jane Yanagawa5, Jay M Lee5, Sherven Sharma2, Denise R Aberle6,7, Arum E Spira8, David A Elashoff9, William D Wallace4, Michael C Fishbein4, Steven M Dubinett1,2,4,7,10

Author Affiliations

1: Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California. KKrysan@mednet.ucla.edu SDubinett@mednet.ucla.edu.
2: VA Greater Los Angeles Healthcare System, Los Angeles, California.
3: Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
4: Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.
5: Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California.
6: Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, California.
7: Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
8: Department of Medicine and Boston University-BMC Cancer Center, Boston University, Boston, Massachusetts.
9: Department of Biostatistics and Biomathematics, David Geffen School of Medicine at UCLA, Los Angeles, California.
10: Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California.

Articles cited by this

Sequencing the Events That Mediate Progression of Premalignant Lung Lesions. Cancer Res (2019) 5.10